India, March 20 -- Tech Mahindra has announced a groundbreaking pharmacovigilance (PV) solution developed in collaboration with NVIDIA. This AI-powered solution leverages agentic artificial intelligence (AI) and automation to enhance drug safety management by improving the accuracy, speed, and efficiency of pharmacovigilance processes.

With pharmaceutical companies dealing with vast amounts of data during clinical trials and post-launch monitoring, the solution addresses key industry challenges such as manual delays and data overload. By integrating NVIDIA AI Enterprise software, including NVIDIA NeMo, NVIDIA NIM microservices, and NVIDIA AI Blueprints, Tech Mahindra's PV solution streamlines case intake, data transformation, quality con...